Sign Up
OverviewAPI
The global antibody therapeutics market is forecasted to hit USD 479 billion by 2028, expanding at a CAGR of 14.1%. North America spearheads the market with major players like AbbVie Inc., Johnson & Johnson, and Bristol-Myers Squibb. Europe's market is poised for substantial growth propelled by companies such as F. Hoffmann-La Roche Ltd., AstraZeneca, and Sanofi. Human source antibodies are predominant, with humanized sources exhibiting notable growth, and intravenous administration emerges as the prevalent route for antibody therapeutics.

Ask a question